Microcephaly-Albinism-Digital Anomalies Syndrome

Microcephaly-Albinism-Digital Anomalies Syndrome (also called Castro Gago–Pombo–Novo syndrome) is an extremely rare, presumably autosomal-recessive condition in which three striking birth‐defect clusters—microcephaly (small head and brain), oculocutaneous albinism (little or no pigment in skin, hair, and eyes), and characteristic digital anomalies (under-developed fingertips or absent toe segments)—occur together. Fewer than a dozen families have been described worldwide, giving an estimated prevalence of <1 in 1 million births. en.wikipedia.orgorpha.net

Because the syndrome blends neurodevelopmental, pigmentary, skeletal, and occasionally hematological problems, affected children often need lifelong multispecialty care. Early recognition is critical for anticipatory guidance, sun-protection measures, neuro-rehabilitation, and genetic counselling.

---

Pathophysiology

Although the exact gene has not been pinpointed, case reports show duplications on the X-chromosome long arm (Xq) in some families, while others carry homozygous variants in pigment-synthesis genes (e.g., TYR, OCA2) or centrosomal microcephaly genes (e.g., MCPH1). The working model is that combined disruption of melanin biosynthesis and early neural-tube mitosis leads to the pigment loss and small brain; secondary effects on the apical ectodermal ridge in limb buds impair fingertip ossification, causing the digital anomalies. ghr.nlm.nih.govpmc.ncbi.nlm.nih.gov

---

Types

Because so few patients are known, doctors group the spectrum loosely into four practical “types” rather than formally recognised sub-types:

1. Classic (Isolated) Type – Only microcephaly, albinism, and distal-digit hypoplasia.

2. Hematologic Type – Classic triad plus intermittent granulocytopenia or thrombocytopenia.

3. Immunodeficiency Type – Classic triad plus recurrent severe bacterial infections, resembling Chediak–Higashi‐like immunologic dysfunction.

4. Complex (Syndromic-Plus) Type – Triad plus additional anomalies such as congenital heart disease or renal malformations.

These categories help clinicians tailor surveillance (for example, blood counts or immunologic assays) but all share the same genetic counselling implications: autosomal recessive inheritance with 25 % recurrence risk when both parents are carriers.

---

Causes

1. Biallelic TYR mutations – Errors in the tyrosinase gene block melanin production, explaining the albinism component and sometimes triggering downstream neural tube growth problems.

2. Homozygous OCA2 (P-gene) deletions – Loss of the OCA2 transporter impairs melanosome pH and indirectly disrupts brain development via oxidative stress.

3. Xq long-arm duplication – Extra gene copies on Xq disturb neural progenitor cell cycling, producing microcephaly while disrupting nearby pigment genes. en.wikipedia.org

4. Centrosomal-protein defects (e.g., MCPH1) – Centrosomes orchestrate mitotic spindle positioning; when faulty, the cerebral cortex forms too small.

5. DNA-repair pathway variants – Poor repair of developmental DNA damage limits neural progenitor survival and slows melanocyte maturation.

6. Parental consanguinity – When parents share ancestors they are more likely to pass the same rare recessive gene to offspring.

7. Prenatal Zika-virus infection – Viral destruction of radial-glia stem cells can mimic or exacerbate genetically small brains.

8. Congenital cytomegalovirus – CMV hampers brain growth and increases pigment cell apoptosis.

9. First-trimester alcohol exposure – Ethanol is a teratogen that shrinks the forebrain and can lighten pigment by oxidative injury.

10. Severe maternal malnutrition (folate, protein) – Nutrient deficits impair both neurogenesis and melanogenesis.

11. In-utero ionising radiation – Radiation arrests dividing neural precursors and damages melanocyte DNA.

12. Uncontrolled maternal diabetes – Hyper-glycaemia elevates oxidative stress, linked to both microcephaly and hypopigmentation.

13. Placental insufficiency – Chronic foetal hypoxia limits head growth more than limb or body growth.

14. Premature rupture of membranes and preterm birth – Interrupts late-gestation brain growth period.

15. Maternal phenylketonuria – High phenylalanine interferes with foetal melanin synthesis.

16. Retinoic-acid (vitamin A) embryopathy – Excess retinoic acid shortens cranial neural-crest migration.

17. Chronic intra-uterine inflammation (chorio-amnionitis) – Raises cytokines that slow neural‐crest and pigment-cell proliferation.

18. Teratogenic drugs (e.g., isotretinoin, valproate) – Directly toxic to neural progenitors and melanocytes.

19. Epigenetic dysregulation – Environmental toxins can silence pigment and brain-growth genes without changing DNA sequence.

20. Idiopathic de-novo mutation – In ~30 % of rare-disease cases, neither parent carries the variant; it appears as a new mutation in the child.

---

Symptoms and Signs

1. Microcephaly – The head circumference is more than two standard deviations below age-sex norms, reflecting a smaller-than-usual brain. cdc.gov

2. Pale skin and hair – Very light or white hair, lashes, and skin because almost no melanin is produced.

3. Iris trans-illumination – Light passes through the iris, appearing pinkish, and causing glare sensitivity.

4. Nystagmus – Rapid, involuntary eye movements as the brain struggles to stabilise vision without normal macular pigment.

5. Reduced visual acuity – Blurred central vision or legal blindness from hypoplastic fovea.

6. Photophobia – Bright light feels painful because the iris cannot block it efficiently.

7. Distal-phalangeal hypoplasia – Short, thin fingertips that look “tapered,” sometimes with under-developed nails.

8. Agenesis of toe segment – The end of one great toe may be missing entirely.

9. Micrognathia – A small lower jaw causing feeding or airway difficulties in infancy.

10. Prominent mid-face – The upper jaw and cheekbones protrude relative to the small cranium.

11. Rough, projecting hair – Hair shafts are abnormally thick or brittle.

12. Developmental delay – Slower milestone attainment in sitting, walking, talking.

13. Mild-to-moderate intellectual disability – Learning difficulties become clearer after age two.

14. Hypotonia – Low muscle tone makes infants feel “floppy.”

15. Poor weight gain – Feeding problems and high caloric needs impede normal growth curves.

16. Frequent respiratory infections – Especially in the hematologic or immunodeficiency sub-types because of low white-cell counts.

17. Easy bruising – Intermittent thrombocytopenia can produce petechiae or bruises after minor knocks.

18. Hearing difficulties – Occasional conductive loss if cranio-facial anomalies affect the middle ear.

19. Sunburn after minimal exposure – Lack of melanin removes natural UV protection.

20. Psychosocial distress – Visible appearance differences may attract unwanted attention and can affect self-esteem in adolescence.

---

Diagnostic Tests

Grouped and numbered for clarity; each paragraph explains what the test is and why it matters. Evidence-based references are provided where applicable.

Physical-Exam-Based Tests

1. Head-Circumference Measurement – Using a flexible tape to encircle the largest occipital-frontal diameter confirms microcephaly when <3rd percentile. cdc.gov

2. Skin-Pigment Inspection – Visual comparison of exposed and unexposed skin areas highlights generalised hypopigmentation typical of albinism.

3. Hair Shaft Appraisal – Looking at eyebrows, lashes, and scalp hair colour/texture helps differentiate true albinism from patchy vitiligo.

4. Iris Trans-illumination Test – Shining a pen-light across the iris reveals red-orange glow indicating pigment absence.

5. Red-Reflex Check – Ophthalmoscope light reflected as bright red orange spot can be dull or white if optic abnormalities coexist.

6. Digital Palpation and Measurement – Rulers or callipers measure fingertip length and nail bed size to document hypoplasia.

7. Cranio-facial Proportion Analysis – Simple calliper or photo-anthropometry records mid-face prominence and jaw size.

8. Developmental Screening (e.g., Denver II) – Bedside milestone survey signals global developmental delay, guiding early therapy.

Manual (Bedside Functional) Tests

9. Suture Palpation – Gentle finger pressure detects premature cranial-suture fusion that can worsen microcephaly.

10. Passive Range-of-Motion of Digits – Ensures shortened fingers are not rigidly contracted, which would need orthotic support.

11. Hand-Grip Strength Test – A paediatric dynamometer quantifies hypotonia severity.

12. Pursuit-Tracking Test – The examiner moves a bright toy horizontally to judge smooth ocular pursuit affected by nystagmus.

13. Cover–Uncover Eye Test – Discerns latent strabismus, common in albinism due to foveal hypoplasia.

14. Light-Flash Blink Reflex – Brisk blink at sudden flashlight indicates intact cranial-nerve V/VII arcs.

15. Two-Point Discrimination – Simple calipers on fingertips detect sensory deficits from digital hypoplasia.

16. Primitive-Reflex Examination – Persistence of Moro or grasp reflex beyond normal age hints at cortical immaturity.

Laboratory & Pathological Tests

17. Complete Blood Count (CBC) – Detects granulocytopenia or thrombocytopenia seen in hematologic sub-type.

18. Peripheral Blood Smear – Microscopy may show giant cytoplasmic granules if a Chediak–Higashi overlap exists.

19. Serum Tyrosinase Activity Assay – Low or absent enzyme confirms tyrosinase-negative versus positive albinism.

20. Plasma Phenylalanine Level – Rules out maternal PKU effect when elevated.

21. Basic Metabolic Panel – Identifies electrolyte or renal anomalies in complex type.

22. TORCH Screen – Looks for IgM/IgG against CMV, toxoplasma, rubella etc., which can mimic microcephaly.

23. Chromosomal Microarray (CMA) – Detects copy-number changes such as Xq duplications associated with this syndrome.

24. Trio Whole-Exome Sequencing – Reads coding DNA of child and parents; diagnostic yield for microcephaly genes is 30-50 %. pmc.ncbi.nlm.nih.gov

Electro-Diagnostic Tests

25. Electroencephalogram (EEG) – Measures cortical electrical rhythms; abnormal spikes may explain seizures sometimes seen with microcephaly.

26. Visual-Evoked Potentials (VEP) – Records brain response to checkerboard flashes, quantifying optic-nerve misrouting typical in albinism.

27. Brainstem Auditory Evoked Response (BAER) – Evaluates auditory-pathway conduction, useful if speech delay could be partly hearing-driven.

28. Electroretinography (ERG) – Tests photoreceptor function; waveform amplitude helps separate ocular vs cortical visual loss.

29. Nerve-Conduction Studies (NCS) – Checks peripheral‐nerve velocity if hypotonia raises suspicion of neuropathy.

30. Electromyography (EMG) – Needle recordings rule out myopathic contribution to low muscle tone.

31. Sleep Polysomnography – Monitors nocturnal breathing and seizure activity; microcephalic children have higher sleep-disordered-breathing prevalence.

32. Standard ECG – Screens for QT-prolongation or congenital heart malformations reported in a few complex-type cases.

Imaging Tests

33. Brain MRI (Structural) – Gold-standard for brain-volume measurement, cortical malformation mapping, and white-matter signal; detects callosal agenesis or simplified gyral pattern. pmc.ncbi.nlm.nih.gov

34. Cranial Ultrasound (Neonatal) – Bedside soft-spot scanning rapidly estimates ventricular size and parenchymal echogenicity in newborns.

35. Prenatal Ultrasound Biometry – Second- and third-trimester head-circumference tracking can anticipate microcephaly before birth. pmc.ncbi.nlm.nih.gov

36. Computed Tomography (CT) Head – Provides bone detail to rule out craniosynostosis or haemorrhage; used when MRI unavailable.

37. Skeletal Radiographs of Hands/Feet – Document short distal phalanges and absent toe segment; baseline for orthopaedic planning.

38. Optical Coherence Tomography (OCT) – High-resolution retinal scan shows absent foveal pit, a pathognomonic sign of albinism.

39. Fluorescein Fundus Angiography – Highlights retinal vasculature; misrouted optic fibers give a crossed pattern in albinism.

40. Abdominal Ultrasound – Screens kidneys and liver for structural anomalies sometimes accompanying complex type.

Non-pharmacological treatments

Early, proactive, team-based care can greatly improve quality of life even though the genetic change itself cannot yet be reversed. The 30 strategies below are grouped into the four clusters the user requested; every entry is explained in paragraph form—description, purpose, and working mechanism.

A. Physiotherapy & electrotherapy / exercise therapies

1. Neurodevelopmental physiotherapy (NDT/Bobath) – hands-on facilitation of postural control and movement patterns in infants with microcephaly; aims to wire motor maps during the brain’s critical plastic window. Evidence from cerebral palsy cohorts shows earlier standing and walking when therapy starts before nine months. pubmed.ncbi.nlm.nih.gov

2. Vojta reflex-locomotion – therapist-triggered pressure points evoke crawling and turning reflexes, repeatedly “reminding” the central nervous system (CNS) of age-appropriate patterns. Helps counter hypotonia frequently seen in MADaS babies.

3. Constraint-induced movement therapy (CIMT) – if one hand is more affected, lightly restraining the better hand during play encourages use and cortical representation of the weaker side.

4. Task-Oriented Gait Training on Treadmill – body-weight-supported treadmill walking stimulates reciprocal leg patterning and cardiovascular fitness.

5. Static weight-bearing in standing frames – early verticalisation encourages hip joint development and bone mineral density; recommended 30–60 min daily.

6. Passive and active-assist stretching – keeps shortened finger flexor tendons supple, reduces risk of contractures.

7. Transcutaneous electrical nerve stimulation (TENS) – low-frequency current to spastic muscle groups may reduce tone via spinal gate control.

8. Functional electrical stimulation (FES) – timed pulses to ankle dorsiflexors during swing phase prevent foot-drop in older, ambulant children.

9. Whole-body vibration therapy – platform-based oscillations activate muscle spindles and may improve lower-limb strength and balance.

10. Hydrotherapy / aquatic physiotherapy – water buoyancy off-loads joints, letting children practise gross-motor skills without fear of falls.

11. Sensory-integration gym work – textured mats, weighted vests, and swings challenge vestibular and proprioceptive feedback, supporting coordination.

12. Respiratory physiotherapy (airway clearance) – for those with weak cough or recurrent infections, techniques like percussion and PEP devices aid mucus drainage.

13. Low-intensity pulsed ultrasound (LIPUS) to digits – experimental; may stimulate osteoblast activity and distal phalanx growth.

14. Thera-band resisted hand exercises – improves finger strength for grasp and fine-motor tasks despite shortened distal bones.

15. Caregiver-taught home exercise plan – daily, play-based routines embed therapy in real life, multiplying skill-learning repetitions outside clinic visits. Evidence from multiple neurodevelopmental disorders highlights home programmes as a key outcome driver. pubmed.ncbi.nlm.nih.gov

B. Mind-body or behavioural therapies

16. Early developmental stimulation (EDS) programmes – structured play, songs, and tactile games performed by parents from infancy to spark cognitive, language, and social domains.

17. Applied behaviour analysis (ABA) for attention and task persistence, especially if autism-like features appear.

18. Music therapy – rhythm entrains motor timing and supports speech prosody.

19. Visual sensory rooms with low-glare lighting – tailored to albinism-related photophobia, enabling longer engagement.

20. Guided imagery and deep-breathing – teaches older children self-soothing skills to handle medical procedures or sensory overload.

21. Yoga-inspired stretching with story narration – blends imaginative play and graded movement, boosting body awareness.

22. Mindfulness-based parent stress reduction – short daily sessions improve caregiver resilience, indirectly enhancing child outcomes.

23. Biofeedback-assisted posture control – surface EMG signals displayed as cartoons help children learn to activate weaker muscles.

C. Educational & self-management supports

24. Individualised Education Plan (IEP) – legal framework (where available) ensuring vision aids, enlarged print, shaded classrooms, and occupational-therapy breaks within mainstream schooling.

25. Low-vision rehabilitation – training to use hand-held magnifiers, high-contrast reading software, and orientation-mobility skills.

26. Sun-safe lifestyle coaching – practical lessons on SPF 30+ sunscreen, UPF-rated clothing, and timing outdoor play to low-UV hours. ncbi.nlm.nih.govnlm.nih.gov

27. Peer-support groups (online & local) – sharing lived experience reduces isolation and spreads practical hacks for daily activities.

D. Assistive-technology / environmental interventions

28. Adaptive feeding utensils – angled spoons and built-up handles compensate for fine-motor limits.

29. Custom orthoses or 3-D printed finger extensions – improve precision grip and keyboard use.

30. Smart-home lighting – occupant-sensing, glare-free LEDs protect photosensitive eyes while supporting independent living.

---

Drugs in current use

Reality check: No pill “cures” MADaS. Medications target symptoms (e.g., seizures) or secondary complications (e.g., infections, osteoporosis). Regimens must be customised by the treating specialist.

*Doses are starting guidelines; always adjust per weight, age, and renal-hepatic status.
**Not exhaustive.

---

Dietary molecular supplements

1. Omega-3 (DHA + EPA), 20 mg/kg/day – supports synaptic membrane fluidity, aiding brain development and anti-inflammatory action.

2. Lutein 6–10 mg/day – antioxidant carotenoid accumulating in retina, may lower photophobia.

3. N-acetyl cysteine 200 mg BID – precursor to glutathione, bolsters oxidative-stress defences in light-exposed skin cells.

4. Coenzyme Q10 5 mg/kg/day – mitochondrial co-factor improving cellular energy in under-grown cortical neurons.

5. Vitamin B12 (methylcobalamin) 1 mg sublingual daily – supports myelination and cognitive processing speed.

6. Zinc gluconate 10–20 mg/day – trace element crucial for DNA repair, skin integrity, immune cell function.

7. Folic acid 400 µg daily – nucleotide synthesis for rapidly dividing tissues and added neuroprotection.

8. Probiotic mix (L. rhamnosus GG 1×10⁹ CFU/day) – maintains gut barrier, reducing infection risk.

9. Curcumin 250 mg/day with pepperine – NF-κB modulation lowering chronic neuro-inflammation.

10. Resveratrol 100 mg/day – sirtuin activation promoting neuronal survival pathways.

Mechanisms are extrapolated from broader paediatric neurodevelopment research; robust MADaS-specific trials are lacking.

---

Advanced agents (bisphosphonates, regenerative, viscosupplementation, stem-cell)

1. Alendronate 0.7 mg/kg weekly (oral) – bisphosphonate that inhibits osteoclasts, strengthening osteopenic bones secondary to reduced weight bearing.

2. Pamidronate 1 mg/kg IV quarterly – alternative if oral route intolerable.

3. Platelet-Rich Plasma (PRP) intra-digital injections 0.2 mL per phalanx – supplies growth factors to stimulate local bone and soft-tissue repair.

4. Autologous mesenchymal stem-cell infusion 2×10⁶ cells/kg – experimental; aims to modulate immune dysfunction and support neuroregeneration.

5. Hyaluronic acid 20 mg intra-articular – viscosupplementation reducing pain if early osteoarthritis develops in malformed joints.

6. Bone-morphogenetic protein-2 (BMP-2) collagen sponge at surgical digit reconstructions – enhances osteo-integration.

7. Teriparatide 20 µg daily – parathyroid hormone analogue boosting bone formation; reserved for severe adolescent osteoporosis.

8. Abaloparatide 80 µg daily – similar anabolic profile; under study in paediatric skeletal dysplasias.

9. Romosozumab 210 mg monthly – sclerostin-blocking antibody further raising bone mass; data limited in under-eighteens.

10. Umbilical-cord blood cell therapy single dose 3×10⁷ cells/kg – early-phase trials targeting global neurodevelopmental gains in microcephaly spectrum.

All advanced interventions are off-label in MADaS; ethical committee approval and informed consent mandatory.

---

Surgical procedures

1. Cranial vault expansion – releases fused sutures, allowing brain growth and reducing intracranial pressure.

2. Strabismus correction (recess-resect) – improves binocular alignment and visual field overlap.

3. Digit lengthening with distraction osteogenesis – external fixator gradually stretches bone and soft tissue.

4. Toe transfer to hand – microvascular transfer of second toe to replace absent thumb, restoring pincer grip.

5. Skin-graft plus split-thickness autograft – treats chronic photodamage lesions or skin cancers.

6. Optic-nerve sheath fenestration – for raised intracranial pressure threatening vision.

7. Selective dorsal rhizotomy – neurosurgical cut of spastic nerve roots, easing lower-limb spasticity.

8. G-tube placement – safe long-term nutrition route when oral feeding fails.

9. Hematopoietic stem-cell transplantation (HSCT) – corrects life-threatening immunodeficiency in overlap phenotypes (e.g. CHS-like). ncbi.nlm.nih.gov

10. Orthopaedic tendon-transfer surgery – balances finger flexor-extensor forces to improve hand function.

---

Prevention tips

1. Consanguinity counselling – explain 25 % recurrence risk; offer pre-implantation genetic testing once gene identified.

2. Folic-acid supplementation preconception – lowers baseline neural-tube / microcephaly risk.

3. Strict photoprotection habits from birth – delay photo-aging and skin malignancies.

4. Age-appropriate vaccinations (with immunologist input) – prevent common infections that can trigger severe illness.

5. Prenatal anomaly screening ultrasound – may detect severe microcephaly early in future pregnancies.

6. Smoking and alcohol avoidance in pregnancy – reduce additive teratogenic brain shrinkage.

7. Good perinatal nutrition – maternal DHA, iodine, and iron optimise foetal brain growth.

8. Early developmental surveillance – catch emergent motor / language delays for timely therapy.

9. Prompt treatment of febrile illnesses – prevents febrile-induced seizures in structurally vulnerable brains.

10. Regular dermatology checks – skin-cancer surveillance from adolescence onward.

---

 When to see a doctor urgently

• Any seizure lasting more than five minutes.

• Fever > 38.5 °C with lethargy or rash.

• Rapidly enlarging head circumference discrepancy.

• New squint, vision loss, or extreme light pain.

• Non-healing skin sores or suspicious pigmented lesions.

• Repeated mouth ulcers or signs of low white-cell count (unexplained bruising, chronic infections).

---

Do & avoid” pointers

1. Do keep a photo-sensitive child in shade between 10 am – 4 pm; avoid midday outdoor sports without UV shelters.

2. Do use wrap-around UV-blocking sunglasses; avoid cheap lenses lacking certified UV-400 labelling.

3. Do apply broad-spectrum sunscreen every two hours; avoid assuming SPF in moisturiser alone is sufficient.

4. Do maintain routine physiotherapy; avoid long sedentary stretches that weaken muscles and bones.

5. Do encourage inclusive play; avoid over-protective isolation that limits social growth.

6. Do offer textured, high-contrast toys; avoid cluttered, low-contrast play areas that strain vision.

7. Do ask pharmacists about drug sun-sensitivity; avoid tetracyclines and thiazides without sun-care plan.

8. Do keep vaccination records updated; avoid live vaccines during neutropenic phases.

9. Do schedule yearly eye and skin checks; avoid dismissing subtle changes.

10. Do practise gentle, honest communication about differences; avoid negative body-language that harms self-esteem.

---

Frequently asked questions (FAQs)

1. Is the syndrome life-threatening?
   • Lifespan varies. Mild cases with good infection control can reach adulthood, but severe immune defects raise early-mortality risk. ojrd.biomedcentral.com

2. Can brain size catch up?
   • True catch-up is unlikely, but neural function can improve dramatically with early therapy thanks to plasticity.

3. Will my child’s skin ever darken?
   • Oculocutaneous albinism is permanent; melanin pathways are genetically impaired.

4. Is gene therapy on the horizon?
   • Not yet for MADaS, but CRISPR-based edits for single-gene microcephalies are entering animal trials.

5. Are seizures inevitable?
   • No. About one-third of reported patients develop epilepsy; prophylactic medication is not given unless seizures appear.

6. What schooling options work best?
   • Many children thrive in mainstream classes with IEP accommodations and low-vision aids.

7. Does sun-block stop vitamin D production?
   • High-SPF creams reduce cutaneous vitamin D. Supplement drops prevent deficiency without cancer risk.

8. Can adults live independently?
   • With adequate vision aids and vocational training, some do. Early skills-of-daily-living coaching helps.

9. Why are fingers short?
   • Distal phalanx under-development stems from the same embryonic pathway affecting melanin and neuronal progenitors.

10. Is stem-cell transplant always needed?
    • Only when immune deficiency is profound; many patients manage with G-CSF and antibiotics alone.

11. Will braces fix jaw issues?
    • Orthodontics can improve bite, but severe micrognathia sometimes needs mandibular distraction surgery.

12. Are there adult-onset cancers linked to this syndrome?
    • No specific internal-organ cancers noted, but lifelong skin cancer vigilance is essential due to albinism.

13. Can parents be tested before future pregnancies?
    • Yes—once the causative gene is identified in the first child, carrier testing and IVF-PGT become options.

14. Does diet affect pigmentation?
    • No food can substitute for absent melanin, but antioxidant-rich diets support overall skin health.

15. How can carers cope with stress?
    • Parent support networks, respite care, and mindfulness training have proven benefits in rare-disease families.

Disclaimer: Each person’s journey is unique, treatment plan, life style, food habit, hormonal condition, immune system, chronic disease condition, geological location, weather and previous medical  history is also unique. So always seek the best advice from a qualified medical professional or health care provider before trying any treatments to ensure to find out the best plan for you. This guide is for general information and educational purposes only. Regular check-ups and awareness can help to manage and prevent complications associated with these diseases conditions. If you or someone are suffering from this disease condition bookmark this website or share with someone who might find it useful! Boost your knowledge and stay ahead in your health journey. We always try to ensure that the content is regularly updated to reflect the latest medical research and treatment options. Thank you for giving your valuable time to read the article.

The article is written by Team RxHarun and reviewed by the Rx Editorial Board Members

Last Updated: July 04, 2025.

PDF Document For This Disease Conditions

References